Form preview

Get the free NOTIFICATION OF A SUBSTANTIAL AMENDMENT TO A CLINICAL TRIAL ON A MEDICINAL PRODUCT F...

Get Form
This document serves as a notification to the competent authorities and ethics committees regarding a substantial amendment in a clinical trial, detailing the purpose, changes made, and contact information
We are not affiliated with any brand or entity on this form

Get, Create, Make and Sign notification of a substantial

Edit
Edit your notification of a substantial form online
Type text, complete fillable fields, insert images, highlight or blackout data for discretion, add comments, and more.
Add
Add your legally-binding signature
Draw or type your signature, upload a signature image, or capture it with your digital camera.
Share
Share your form instantly
Email, fax, or share your notification of a substantial form via URL. You can also download, print, or export forms to your preferred cloud storage service.

How to edit notification of a substantial online

9.5
Ease of Setup
pdfFiller User Ratings on G2
9.0
Ease of Use
pdfFiller User Ratings on G2
Follow the steps below to benefit from the PDF editor's expertise:
1
Set up an account. If you are a new user, click Start Free Trial and establish a profile.
2
Prepare a file. Use the Add New button to start a new project. Then, using your device, upload your file to the system by importing it from internal mail, the cloud, or adding its URL.
3
Edit notification of a substantial. Rearrange and rotate pages, add and edit text, and use additional tools. To save changes and return to your Dashboard, click Done. The Documents tab allows you to merge, divide, lock, or unlock files.
4
Get your file. Select your file from the documents list and pick your export method. You may save it as a PDF, email it, or upload it to the cloud.
It's easier to work with documents with pdfFiller than you could have ever thought. Sign up for a free account to view.

Uncompromising security for your PDF editing and eSignature needs

Your private information is safe with pdfFiller. We employ end-to-end encryption, secure cloud storage, and advanced access control to protect your documents and maintain regulatory compliance.
GDPR
AICPA SOC 2
PCI
HIPAA
CCPA
FDA

How to fill out notification of a substantial

Illustration

How to fill out NOTIFICATION OF A SUBSTANTIAL AMENDMENT TO A CLINICAL TRIAL ON A MEDICINAL PRODUCT FOR HUMAN USE

01
Identify the substantial amendment that needs to be notified.
02
Prepare the appropriate notification form as required by the regulatory authority.
03
Provide detailed information about the amendment, including the reasons for the change.
04
Include relevant documents and supplementary information that explain the amendment.
05
Submit the notification form to the relevant regulatory authority, ensuring that it is done within the specified timeline.
06
Await confirmation from the regulatory authority regarding the acceptance of the amendment notification.

Who needs NOTIFICATION OF A SUBSTANTIAL AMENDMENT TO A CLINICAL TRIAL ON A MEDICINAL PRODUCT FOR HUMAN USE?

01
Researchers or sponsors conducting a clinical trial on a medicinal product for human use.
02
Clinical trial coordinators who are responsible for managing the trial compliance.
03
Regulatory authorities that oversee the approval and monitoring of clinical trials.
Fill form : Try Risk Free
Users Most Likely To Recommend - Summer 2025
Grid Leader in Small-Business - Summer 2025
High Performer - Summer 2025
Regional Leader - Summer 2025
Easiest To Do Business With - Summer 2025
Best Meets Requirements- Summer 2025
Rate the form
4.0
Satisfied
47 Votes

People Also Ask about

Amendments to the trial are regarded as “substantial” where they are likely to have a significant impact on: the safety or physical or mental integrity of the subjects, or the scientific value of the trial, or the conduct or management of the trial, or the quality or safety of any IMP used in the trial.
Please use the Notice of Substantial Amendment form available in IRAS. This is created from the Amendment tab associated with the RTB/RDB form. The completed Notice of Substantial Amendment form should be electronically authorised by all parties listed on the form's authorisations tab in IRAS.
An amendment is considered as substantial if the modification has a significant impact on: - Security or physical or mental integrity of the subject. - Scientific value of the trial. - Organization and execution manner of the trial.
A substantial amendment is defined as change to the terms of the protocol or any other supporting documentation that is likely to affect to a significant degree: the safety or physical or mental integrity of participants. the scientific value of the research.
An amendment is considered as substantial if the modification has a significant impact on: - Security or physical or mental integrity of the subject. - Scientific value of the trial. - Organization and execution manner of the trial.
A substantive amendment is one that alters the legal theory of the action or defense, changes the cause of action or its nature, adds a new cause of action, brings in new parties, or otherwise significantly affects the issues in the case.
Notifying substantial amendments A copy of the completed Amendment tool should be included as part of both, submission to the REC, and notification to the MHRA. An updated PDF file of the Clinical Trial Application Form with changes highlighted, if the amendment affects the information previously submitted.

For pdfFiller’s FAQs

Below is a list of the most common customer questions. If you can’t find an answer to your question, please don’t hesitate to reach out to us.

It is a formal communication to regulatory authorities regarding significant changes in the design, conduct, or other essential aspects of a clinical trial involving a medicinal product for human use.
The sponsor of the clinical trial or their appointed representative is typically required to file this notification.
The notification should be completed using the designated form provided by the regulatory authority, including details of the amendment, the reason for the change, and its impact on the trial.
The purpose is to ensure that regulatory bodies are informed of significant changes that could affect the safety, efficacy, or conduct of the clinical trial, thereby maintaining oversight and participant safety.
The notification must report detailed information about the amendment, including the nature of the change, reasons for the amendment, potential impacts on the trial, and any adjustments required in participant consent forms.
Fill out your notification of a substantial online with pdfFiller!

pdfFiller is an end-to-end solution for managing, creating, and editing documents and forms in the cloud. Save time and hassle by preparing your tax forms online.

Get started now
Form preview
If you believe that this page should be taken down, please follow our DMCA take down process here .
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.